OncoScreen® Plus Cancer Mutation Profiling Tissue Kit
Tissue-based large oncopanel for cancer patients
OncoScreen® Plus Cancer Mutation Profiling Tissue Kit is a CE-marked large oncopanel tissue kit for cancer patients. It is a NGS-based in vitro diagnostic device intended to be used for the qualitative detection of multiple types of mutations involving 518 genes based on formalin-fixed paraffin-embedded (FFPE) tissue samples from patients with various cancers. Mutations include point mutationundefined insertion-deletion (InDel) mutationundefined rearrangement (fusion)undefined and copy number variation (CNV)undefined as well as the determination of microsatellite instability (MSI) status and tumor mutation burden (TMB).
- Targeted Therapy
- DDR Genes
- MRD Assessment
- Inherit Subceptibility
- TMB Assessment
- IO Therapy Prediction Genes
The test can provide comprehensive guidance on personalized treatment options for various cancers.